Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2001-08-22
2004-05-25
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S119000, C544S071000, C514S234500
Reexamination Certificate
active
06740651
ABSTRACT:
DESCRIPTION OF THE INVENTION
The present invention relates to bicyclic heterocycles of general formula
the tautomers, the stereoisomers and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases which have valuable pharmacological properties, especially an inhibitory effect on signal transduction mediated by tyrosine kinases, the use thereof for treating diseases, particularly tumoral diseases, diseases of the lungs and respiratory tract, and the preparation thereof.
In the above general formula I
R
a
denotes a hydrogen atom or a methyl group,
R
b
denotes a phenyl, benzyl- or 1-phenylethyl group wherein the phenyl nucleus is substituted in each case by the groups R
1
to R
3
, while
R
1
and R
2
, which may be identical or different, in each case denote a hydrogen, fluorine, chlorine, bromine or iodine atom,
a methyl, ethyl, hydroxy, methoxy, ethoxy, amino, cyano, vinyl or ethynyl group,
an aryl, aryloxy, arylmethyl or arylmethoxy group,
a methyl or methoxy group substituted by 1 to 3 fluorine atoms or
R
1
together with R
2
, if they are bound to adjacent carbon atoms, denote a —CH═CH—CH═CH, —CH═CH—NH—or —CH═N—NH group and
R
3
denotes a hydrogen, fluorine, chlorine or bromine atom,
R
c
denotes a hydrogen atom or a methyl group,
X denotes a methyne group substituted by a cyano group or a nitrogen atom,
A denotes a 1,1- or 1,2-vinylene group which may be substituted in each case by one or two methyl groups or by a trifluoromethyl group,
an ethynylene group or
a 1,3-butadien-1,4-ylene group optionally substituted by a methyl or trifluoromethyl group,
B denotes an alkylene or —CO-alkylene group wherein the alkylene moiety in each case contains 1 to 4 carbon atoms, while the linking of the —CO-alkylene group to the adjacent group A in each case must take place via the carbonyl group,
a —CO—O-alkylene- or —CO—NR
4
-alkylene group wherein the alkylene moiety in each case contains 1 to 4 carbon atoms, while the linking to the adjacent group A in each case must take place via the carbonyl group, wherein
R
4
denotes a hydrogen atom or a methyl or ethyl group,
or a carbonyl group,
C denotes a 2-oxo-morpholin-4-yl group substituted by the group R
5
or by the group R
5
and a C
1-4
-alkyl group, while
R
5
denotes a C
3-4
-alkyl, hydroxy-C
1-4
-alkyl, C
1-4
-alkoxy-C
1-4
-alkyl, di-(C
1-4
-alkyl)-amino-C
1-4
-alkyl, pyrrolidino-C
1-4
-alkyl, piperidino-C
1-4
-alkyl, morpholino-C
1-4
-alkyl, 4-(C
1-4
-alkyl)-piperazino-C
1-4
-alkyl, C
1-4
-alkylsulphanyl-C
1-4
-alkyl, C
1-4
-alkylsulphinyl-C
1-4
-alkyl, C
1-4
-alkylsulphonyl-C
1-4
-alkyl, cyano-C
1-4
-alkyl, C
1-4
-alkoxycarbonyl-C
1-4
-alkyl, aminocarbonyl-C
1-4
-alkyl, C
1-4
-alkyl-aminocarbonyl-C
-14
-alkyl, di-(C
1-4
-alkyl)aminocarbonyl-C
1-4
-alkyl, pyrrolidinocarbonyl-C
1-4
-alkyl, piperidinocarbonyl-C
1-4
-alkyl, morpholinocarbonyl-C
1-4
-alkyl or a 4-(C
1-4
-alkyl)-piperazino-carbonyl-C
1-4
-alkyl group,
a 2-oxo-morpholin-4-yl group substituted by two groups R
5
, where R
5
is as hereinbefore defined and the two groups R
5
may be identical or different,
a 2-oxo-morpholin-4-yl group, wherein the two hydrogen atoms of a methylene group are replaced by a —(CH
2
)
m
, —CH
2
—Y—CH
2
, —CH
2
—Y—CH
2
—CH
2
, —CH
2
CH
2
—Y—CH
2
CH
2
— or —CH
2
CH
2
—Y—CH
2
CH
2
CH
2
— bridge optionally substituted by one or two C
1-2
-alkyl groups, while
m denotes the number 2, 3, 4, 5 or 6 and
Y denotes an oxygen or sulphur atom, a sulphinyl, sulphonyl or C
1-4
-alkylimino group,
a 2-oxo-morpholin-4-yl group, wherein a hydrogen atom in the 5 position together with a hydrogen atom in the 6 position is replaced by a —(CH
2
)
n
, —CH
2
—Y—CH
2
, —CH
2
—Y—CH
2
CH
2
— or —CH
2
CH
2
—Y—CH
2
-bridge, while
Y is as hereinbefore defined and
n denotes the number 2, 3 or 4,
or, if D together with E denotes a group R
d
, it may also denote a 2-oxo-morpholin-4-yl group which may be substituted by 1 to 4 C
1-2
-alkyl groups,
D denotes a —O—C
1-6
-alkylene group, while the alkylene moiety is linked to the group E, or
an oxygen atom, while this may not be linked to a nitrogen atom of the group E, and
E denotes an amino group substituted by 2 C
1-4
-alkyl groups, wherein the alkyl groups may be identical or different and each alkyl moiety may be substituted from the 2 position by a C
1-4
-alkoxy or di-(C
1-4
-alkyl)-amino group or by a 4- to 7-membered alkyleneimino group, while in the abovementioned 6- to 7-membered alkyleneimino groups in each case a methylene group may be replaced in the 4 position by an oxygen or sulphur atom or by a sulphinyl, sulphonyl- or N-(C
1-4
-alkyl)-imino group,
a 4- to 7-membered alkyleneimino group optionally substituted by 1 to 4 methyl groups,
a 6- to 7-membered alkyleneimino group optionally substituted by 1 or 2 methyl groups, wherein in each case a methylene group in the 4 position is replaced by an oxygen or sulphur atom or by a sulphinyl, sulphonyl- or N-(C
1-4
-alkyl)-imino group,
an imidazolyl group optionally substituted by 1 to 3 methyl groups,
a C
5-7
-cycloalkyl group, wherein a methylene group is replaced by an oxygen or sulphur atom or by a sulphinyl, sulphonyl or N-(C
1-4
-alkyl)-imino group, or
D together with E denotes a hydrogen atom,
a C
1-6
-alkoxy group optionally substituted from the 2 position by a hydroxy- or C
1-4
-alkoxy group,
a C
3-7
-cycloalkoxy- or C
3-7
-cycloalkyl-C
1-4
-alkoxy group,
or a group R
d
, where
R
d
denotes a C
2-6
-alkoxy group which is substituted from the 2 position by a C
4-7
-cycloalkoxy- or C
3-7
- cycloalkyl-C
1-3
-alkoxy group,
a C
4-7
-cycloalkoxy- or C
3-7
-cycloalkyl-C
1-6
-alkoxy group wherein the cycloalkyl moiety in each case is substituted by a C
1-4
-alkyl, C
1-4
-alkoxy, di-(C
1-4
-alkyl)-amino, pyrrolidino, piperidino, morpholino, piperazino, 4-(C
1-2
-alkyl)-piperazino, C
1-4
-alkoxy-C
1-2
-alkyl, di-(C
1-4
-alkyl)-amino-C
1-2
-alkyl, pyrrolidino-C
1-2
-alkyl, piperidino-C
1-2
-alkyl, morpholino-C
1-2
-alkyl, piperazino-C
1-2
-alkyl- or 4-(C
1-2
-alkyl)-piperazino-C
1-2
-alkyl group, while the abovementioned cycloalkyl moieties may additionally be substituted by a methyl or ethyl group,
while, unless otherwise stated, by the aryl moieties mentioned in the definition of the abovementioned groups is meant a phenyl group which may be mono- or disubstituted by R
6
, while the substituents may be identical or different and
R
6
denotes a fluorine, chlorine, bromine or iodine atom, a C
1-2
-alkyl, trifluoromethyl or C
1-2
-alkoxy group, or
two groups R
6
, if they are bound to adjacent carbon atoms, together represent a C
3-4
-alkylene, methylenedioxy or 1,3-butadien-1,4-ylene group.
Preferred compounds of the above general formula I are those wherein
R
a
denotes a hydrogen atom,
R
b
denotes a benzyl or 1-phenylethyl group or a phenyl group substituted by the groups R
1
and R
2
, while
R
1
denotes a hydrogen, fluorine, chlorine or bromine atom, a methyl, trifluoromethyl, cyano or ethynyl group and
R
2
denotes a hydrogen or fluorine atom,
R
c
denotes a hydrogen atom,
X denotes a nitrogen atom,
A denotes a 1,2-vinylene group,
B denotes a C
1-4
-alkylene group,
C denotes a 2-oxo-morpholin-4-yl group substituted by the group R
5
or by the group R
5
and a C
1-4
-alkyl group, while
R
5
denotes a C
3-4
-alkyl, C
1-2
-alkoxy-C
1-4
-alkyl, di-(C
1-2
-alkyl)-amino-C
1-4
-alkyl, pyrrolidino-C
1-4
-alkyl, piperidino-C
1-4
-alkyl, morpholino-C
1-4
-alkyl, 4-(C
1-2
-alkyl)-piperazino-C
1-4
-alkyl, C
1-2
-alkylsulphanyl-C
1-4
-alkyl, C
1-2
-alkylsulphinyl-C
1-4
-alkyl, C
1-2
-alkylsulphonyl-C
1-4
-alkyl, cyano-C
1-4
-alkyl, C
1-2
-alkoxycarbonyl-C
1-4
-alkyl, aminocarbonyl-C
1-4
-alkyl, C
1-2
-alkyl-aminocarbonyl-C
1-4
-alkyl, di-(C
1-2
-alkyl)-aminocarbonyl-C
1-4
-alkyl, pyrrolidinocarbonyl-C
1-4
-alkyl, piperidinocarbonyl-C
1-4
-alkyl, morpholinocarbonyl-C
1-4
-alkyl- or a 4-(C
1-2
-alkyl)-piperazinocarbonyl-C
1-4
-alkyl group,
a 2-oxo-morpholin-4-yl group substituted by two groups R
5
, while R
5
is as hereinbefore defined and the two groups R
5
may be identical or different,
a 2-oxo-morpholi
Blech Stefan
Himmelsbach Frank
Jung Birgit
Langkopf Elke
Solca Flavio
Boehringer Ingelheim Pharma KG
Devlin Mary-Ellen M.
Liu Hong
Raymond Richard L.
Raymond Robert P.
LandOfFree
Aminoquinazolines which inhibit signal transduction mediated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminoquinazolines which inhibit signal transduction mediated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminoquinazolines which inhibit signal transduction mediated... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3259153